Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, Testolin A, Bevilacqua P
St Bortolo Regional Medical Centre, Vicenza, Italy.
Int J Cancer. 1993 Nov 11;55(5):739-44. doi: 10.1002/ijc.2910550507.
Squamous-cell carcinoma of the head and neck includes a heterogeneous group of tumours of the upper air and food passages for which prognosis is difficult to assess. In fact, patients in comparable stages may have diverse clinical courses and responses to similar treatments. In order to better define the prognosis of each patient there is therefore a need to identify novel biological markers which reflect more accurately growth rate, progression and metastatic potential of each tumour. We assessed whether metastases correlate with microvessel counts (i.e. intratumoral vascularity) using the CD-31 monoclonal antibody (MAb) and p53 mutant protein expression, determined in the primary by immunocytochemical methods in 70 patients with locally advanced head and neck cancer. Patients were treated with concurrent chemo-radiotherapy; 50 of these presented loco-regional node metastasis at diagnosis whereas 3 cases, initially node-negative, developed distant metastasis during the period of observation. No feature was predictive for objective response to treatment. The overall mean and median blood vessel density at "hot spots" was 37.42 and 36, respectively, and 57% of the tumours expressed p53 mutant proteins. These 2 biological markers were significantly associated. Patients with metastases (loco-regional and distant) had a significantly higher mean blood-vessel density than those without tumour spread. Also, patients with p53-positive (+/++) tumours had a significantly higher incidence of metastasis than those with negative ones. Multivariate analysis showed that both vascularity and stage, but not p53 expression, are significant and independent predictors of metastasis in this series.
头颈部鳞状细胞癌包括一组异质性的上呼吸道和消化道肿瘤,其预后难以评估。事实上,处于可比分期的患者可能有不同的临床病程以及对相似治疗的反应。因此,为了更好地界定每位患者的预后,有必要识别出能更准确反映每个肿瘤生长速率、进展和转移潜能的新型生物标志物。我们采用CD-31单克隆抗体(MAb)评估转移是否与微血管计数(即肿瘤内血管形成)相关,并通过免疫细胞化学方法在70例局部晚期头颈部癌患者的原发肿瘤中测定p53突变蛋白表达。患者接受同步放化疗;其中50例在诊断时出现局部区域淋巴结转移,而3例最初淋巴结阴性的患者在观察期内发生远处转移。没有特征可预测对治疗的客观反应。“热点”处的总体平均和中位血管密度分别为37.42和36,57%的肿瘤表达p53突变蛋白。这两种生物标志物显著相关。发生转移(局部区域和远处)的患者平均血管密度显著高于无肿瘤扩散的患者。此外,p53阳性(+/++)肿瘤患者的转移发生率显著高于阴性患者。多变量分析表明,在本系列中,血管形成和分期而非p53表达是转移的显著且独立的预测因素。